Advertisement

Topics

InDex Pharmaceuticals AB Gets New Patent In The U.S.

20:00 EDT 11 Oct 2017 | BioSpace

STOCKHOLM, Oct. 12, 2017 /PRNewswire/ --InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod will be issued by the United States Patent and Trademark Office (USPTO). The patent provides additional protection for treating chronic active...

Original Article: InDex Pharmaceuticals AB Gets New Patent In The U.S.

NEXT ARTICLE

More From BioPortfolio on "InDex Pharmaceuticals AB Gets New Patent In The U.S."

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...